Cardioversion of atrial fibrillation in obese patients: Results from the Cardioversion-BMI randomized controlled trial.

Voskoboinik A, Moskovitch J, Plunkett G, Bloom J, Wong G, Nalliah C, Prabhu S, Sugumar H, Paramasweran R, McLellan A, Ling LH, Goh CY, Noaman S, Fernando H, Wong M, Taylor AJ, Kalman JM, Kistler PM. Cardioversion of atrial fibrillation in obese patients: Results from the Cardioversion-BMI randomized controlled trial. J Cardiovasc Electrophysiol. 2019 02; 30(2):155-161.

View in: PubMed

subject areas

Aged
Atrial Fibrillation
Body Mass Index
Cross-Over Studies
Defibrillators
Electric Countershock
Equipment Design
Female
Humans
Male
Middle Aged
Obesity
Prospective Studies
Retreatment
Treatment Failure
Victoria

authors with profiles

Andrew Taylor, Ph.D.

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support